Press Releases

NEW YORK, Oct. 21, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) President and CEO, Anthony Hayes, today released a letter to shareholders outlining the Company's plans for its previously disclosed dividend distribution.

SAN FRANCISCO, Oct. 21, 2019 /PRNewswire/ -- Amygdala Neurosciences (a private company) has been awarded up to $1.35 million NIH grant support for the project titled "26- & 39-Week Toxicity Studies of ANS-6637 in Rats and Monkeys (respectively) to Enable 6+ Months Dosing in Alcohol (and other Substance) Use Disorder Phase 3 Studies.

BARCELONA, Spain, Oct. 21, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new two-year data from the long-term extension of the Phase 3 UNIFI study. The data demonstrated that the majority of adult patients with moderately to severely active ulcerative colitis who achieved symptomatic remission1 with STE

CARLSBAD, Calif., Oct. 21, 2019 /PRNewswire/ -- For biological researchers looking to reduce their reliance on cold storage without disrupting their existing workflow, Thermo Fisher Scientific's new cell culture media are the first to remain stable at room temperature.

LONG BEACH, Calif., Oct. 21, 2019 /PRNewswire/ -- SCAN Health Plan®, one of the nation's largest not-for-profit Medicare Advantage plans, has earned a 4.5-star rating*

LOUISVILLE, Ky., and REDMOND, Wash., Oct. 21, 2019 /PRNewswire/ -- On Monday, Humana and Microsoft Corp. announced a strategic partnership focused on building modern health care solutions for Humana members aimed at improving their health outcomes and making their health care experiences simpler to

LANDOVER, Md., Oct. 21, 2019 /PRNewswire/ -- November is National Epilepsy Awareness Month and the Foundation is rolling out #StaySafeSide, a nationwide effort to highlight the importance of recognizing a seizure and promote seizure first aid. The Foundation is also expanding a series of Public Service Announcements (PSAs) focused on seizure first aid to include two new

CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ -- Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and nonalcoholic steatohepatitis (NASH), today announced that the first IPF patient has been dosed in a clinical trial of the comp

WHIPPANY, N.J., Oct. 21, 2019 /PRNewswire/ -- Bayer today announced recipients of the inaugural Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a U.S.-based research grant program created to support clinical research in pulmonary hypertension (PH), with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The

SAN DIEGO and VANCOUVER, British Columbia, Oct. 21, 2019 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, toda